跳至主要内容
临床试验/RBR-7y2gbdf
RBR-7y2gbdf进行中(未招募)2 期

Treatment of American Tegumentary Leishmaniasis due to Leishmania (Viannia) guyanensis with a combination regimen of Pentamidine and Tamoxifen. Randomized clinical trial

Silmara Navarro Pennini0 个研究点开始时间: 2023年5月11日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 65Y(—)

入选标准

  • Aged from 18 to 65 years; diagnosis of Cutaneous Leishmaniasis confirmed by direct parasitological examination; with a maximum of six lesions; without previous treatment

排除标准

  • Women of childbearing age not using contraceptives; pregnant; lactating women; patients who had already had leishmaniasis; presence of comorbidities; patients under treatment with immunosuppressants or drugs that prolong the QT interval; patients with difficulties in attending planned visits in the study

研究者

发起方
Silmara Navarro Pennini

相似试验